In summary, DKK1 exerts its immunomodulatory effects by enhancing Th2 cell responses, impairing T cell function via myeloid-derived suppressor cell (MDSC) regulation, and inhibiting the growth of CD8+ T lymphocytes and NK cells, thereby enhancing inflammation and cancer immune escape [16]. Here, DKK1 is linked to cancer.